About the IHE/CAPT Real World Evidence Workshop

21 October 2018 
Toronto, Ontario

On October 21, 2018, in conjunction with the 2018 Annual CAPT Conference, the Institute of Health Economics (IHE) and the Canadian Association for Population Therapeutics (CAPT) co-hosted the IHE/CAPT Real World Evidence Workshop. The intent of the workshop was to identify key opportunities for RWE to support decision-making throughout the pharmaceutical product life cycle, as well as the evidence standards required to be considered ‘decision-grade.’ A total of 87 individuals registered for the event, including four speakers. Participants reflected the perspectives of regulators, public payers, clinicians/providers, academia, health technology assessment (HTA) agencies, patient advocates, and industry. The format for the day was an abbreviated Design Sprint.

The objectives of the workshop were to:

  1. identify the value and applications of RWE in supporting pharmaceutical regulatory and reimbursement decision-making; and
  2. identify the conditions upon which RWE will be considered of sufficient quality to inform decision-making.
 Summary report coming soon